Journals / Turkish Journal of Medical Sciences / 2022 / Cilt: 52 - Sayı: 3

Radiomics analysis of uterine tumors in 18F-fluorodeoxyglucose positron emission tomography for prediction of lymph node metastases in endometrial carcinoma

Pages
762–769
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: The radiomics analysis of intratumoral heterogeneity is a promising method for improving triage of the patients for lymph node dissection in endometrial carcinoma.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background/aim: In this single-center study, we aimed to analyze texture features of primary uterine lesions on 18F-FDG PET/CT to predict lymph node metastases.
📊
Key Findings & Data:Material and methods: Totally, 157 (mean age: 62 ± 10.2 years) patients were included in the analysis.
💡
Conclusion & Impact:Conclusion: The radiomics analysis of intratumoral heterogeneity is a promising method for improving triage of the patients for lymph node dissection in endometrial carcinoma.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Background/aim: In this single-center study, we aimed to analyze texture features of primary uterine lesions on 18F-FDG PET/CT to predict lymph node metastases. Material and methods: Totally, 157 (mean age: 62 ± 10.2 years) patients were included in the analysis. Histopathological examination results were considered as the standard reference for nodal involvement. On $^{18}F-FDG PET/CT$ images, only the primary tumor was segmented. SUVmax, SUVmean, SUVpeak, MTV, and TLG of primary uterine lesions were calculated for analyses. For texture analysis first, second, and higher-order texture features were calculated. Results: Mean diameter of primary uterine lesions was calculated as 35± 18.1 mm. Lymph node metastases were detected in 19% of patients in histopathological examination of surgical materials. While 26 patients had pelvic lymph node metastases, 19 patients had additional paraaortic lymph node metastases. On radiomics analysis for 20 features, a significant difference was found between patients with and without lymph node metastasis. With using data mining methods GLZLM ZLNU, EntropyGLCM, Entropyhisto, GLRLM LRHGE, GLZLM HGZE, GLZLM SZHGE, GLRLM HGRE, GLRLM SRHGE were found significant radiomics features to predict lymph node metastasis with a diagnostic accuracy of 0.8. Conclusion: The radiomics analysis of intratumoral heterogeneity is a promising method for improving triage of the patients for lymph node dissection in endometrial carcinoma.

🔖

Cite This Article

SOYDAL, Ç., ARAZ, M., VARLI, B., TAŞKIN, S., ORTAÇ, U. F., BAKIRARAR, B. (2022). Radiomics analysis of uterine tumors in 18F-fluorodeoxyglucose positron emission tomography for prediction of lymph node metastases in endometrial carcinoma. Turkish Journal of Medical Sciences, Cilt: 52 - Sayı: 3, 762–769. https://ajindex.com/articles/609255

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. International Journal of Cancer 2015
  2. 136 (5): E359-386. doi: 10.1002/ijc.29210 2. Jemal A, Murray T, Ward E, Samuels A, Tiwari RC et al. Cancer statistics. CA A Cancer Jornal of Clinicians 2005
  3. 55 (1): 10-30. doi: 10.3322/canjclin.55.1.10 3. Lewin SN, Herzog TJ, Medel NIB, Deutsch I, Burke WM et al. Comparative performance of the 2009 international federation of gynecology and obstetrics’ staging system for uterine corpus cancer. Obstetrics and Gynecology 2010
  4. 116 (5): 1141-1149. doi: 10.1097/AOG.0b013e3181f39849 4. Mariani A, Dowdy SC, Cliby WA, Gostout BS, Jones MB et al. Prospective assessment of lymphatic dissemination in endometrial cancer: a paradigm shift in surgical staging. Gynecological Oncology 2008
  5. doi: 10.1016/j. ygyno.2008.01.023 5. Dowdy SC, Borah BJ, Bakkum-Gamez JN, Weaver AL, McGree ME et al. Prospective assessment of survival, morbidity, and cost associated with lymphadenectomy in low-risk endometrial cancer. Gynecological Oncology 2012
  6. doi: 10.1016/j. ygyno.2012.06.035 6. Seracchioli R, Solfrini S, Mabrouk M, Facchini C, Di Donato N et al. Controversies in surgical staging of endometrial cancer. Obstetrics and Gynecology International 2010
  7. 181963. doi: 10.1155/2010/181963 7. Kitchener H, Swart AM, Qian Q, Amos C, Parmar MK. Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study. Lancet 2009
  8. 373 (9658): 125-136. doi 10.1016/S0140-6736(08)61766-3 8. Crivellaro C, Baratto L, Dolci C, De Ponti E, Magni S et al. Sentinel node biopsy in endometrial cancer: an update. Clinical Translational Imaging 2018
  9. 6 (2): 91-100. doi: 10.1007/s40336- 018-0268-9 9. Türkmen O, Başaran D, Karalök A, Cömert Kimyon G, Taşçı T et al. Prognostic effect of isolated paraaortic nodal spread in endometrial cancer. Journal of the Turkish-German Gynecological Association 2018
  10. 19 (4): 201-205. doi: 10.4274/ jtgga.2017.0152 10. Taskın S, Sarı ME, Altın D, Ersöz CC, Gökçe A et al. Risk factors for failure of sentinel lymph node mapping using indocyanine green/near-infrared fluorescent imaging in endometrial cancer. Archives of Gynecology and Obstetrics 2019
  11. 299 (6): 1667-1672. doi: 10.1007/s00404-019-05137-5 11. Signorelli M, Crivellaro C, Buda A, Guerra L, Fruscio R et al. Staging of high-risk endometrial cancer with PET/C